This content is from: Patents

GSK expands royalty-free licence to HIV drugs

An HIV drugs company set up by GlaxoSmithKline and Pfizer is to offer generic drugs manufacturers a royalty-free voluntary licence to all its healthcare products

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial